Drug Facts
138f0f62-c5d2-457c-8a29-c44fd84aefde
34390-5
HUMAN OTC DRUG LABEL
Drug Facts
Composition & Product
Identifiers & Packaging
Description
Olopatadine (0.2%) (equivalent to olopatadine hydrochloride 0.222%)
Purpose
Antihistamine
Medication Information
Purpose
Antihistamine
Description
Olopatadine (0.2%) (equivalent to olopatadine hydrochloride 0.222%)
Use
temporarily relieves itchy eyes due to pollen, ragweed, grass, animal hair and dander.
Section 50565-1
Keep out of reach of children. If swallowed, get medical help or contact a Poison Control Center right away.
Section 50566-9
Stop use and ask a doctor if you experience:
- eye pain
- changes in vision
- increased redness of the eye
- itching worsens or lasts for more than 72 hours
Section 51945-4
Principal Display Panel Text for Container Label:
NDC 17478-312-12
Olopatadine HCl Ophthalmic
Solution, USP 0.2%
Antihistamine
ONCE DAILY
STERILE 2.5 mL (0.085 FL OZ)
Warnings
For external use only
Directions
-
adults and children 2 years of age and older:
- put 1 drop in the affected eye(s) once daily, no more than once per day
- if using other ophthalmic products while using this product, wait at least 5 minutes between each product
- replace cap after each use
- children under 2 years of age: consult a doctor
Do Not Use
- if solution changes color or becomes cloudy
- if you are sensitive to any ingredient in this product
- to treat contact lens related irritation
Questions?
Call toll-Free 1-800-932-5676 weekdays, 7:00 AM - 5:30 PM CST
Active Ingredient
Olopatadine (0.2%)
(equivalent to olopatadine hydrochloride 0.222%)
Other Information
- only for use in the eye
- store at 4° to 25°C (39° to 77°F).
Inactive Ingredients
benzalkonium chloride 0.01%, dibasic sodium phosphate, edetate disodium, hydrochloric acid/sodium hydroxide (adjust pH), povidone, sodium chloride, and water for injection
When Using the Product
- do not touch tip of container to any surface to avoid contamination
- remove contact lenses before use
- wait at least 10 minutes before reinserting contact lenses after use
- do not wear a contact lens if your eye is red
Structured Label Content
Use
temporarily relieves itchy eyes due to pollen, ragweed, grass, animal hair and dander.
Section 50565-1 (50565-1)
Keep out of reach of children. If swallowed, get medical help or contact a Poison Control Center right away.
Section 50566-9 (50566-9)
Stop use and ask a doctor if you experience:
- eye pain
- changes in vision
- increased redness of the eye
- itching worsens or lasts for more than 72 hours
Section 51945-4 (51945-4)
Principal Display Panel Text for Container Label:
NDC 17478-312-12
Olopatadine HCl Ophthalmic
Solution, USP 0.2%
Antihistamine
ONCE DAILY
STERILE 2.5 mL (0.085 FL OZ)
Purpose
Antihistamine
Warnings
For external use only
Directions
-
adults and children 2 years of age and older:
- put 1 drop in the affected eye(s) once daily, no more than once per day
- if using other ophthalmic products while using this product, wait at least 5 minutes between each product
- replace cap after each use
- children under 2 years of age: consult a doctor
Do Not Use (Do not use)
- if solution changes color or becomes cloudy
- if you are sensitive to any ingredient in this product
- to treat contact lens related irritation
Questions?
Call toll-Free 1-800-932-5676 weekdays, 7:00 AM - 5:30 PM CST
Active Ingredient (Active ingredient)
Olopatadine (0.2%)
(equivalent to olopatadine hydrochloride 0.222%)
Other Information (Other information)
- only for use in the eye
- store at 4° to 25°C (39° to 77°F).
Inactive Ingredients (Inactive ingredients)
benzalkonium chloride 0.01%, dibasic sodium phosphate, edetate disodium, hydrochloric acid/sodium hydroxide (adjust pH), povidone, sodium chloride, and water for injection
When Using the Product (When using the product)
- do not touch tip of container to any surface to avoid contamination
- remove contact lenses before use
- wait at least 10 minutes before reinserting contact lenses after use
- do not wear a contact lens if your eye is red
Advanced Ingredient Data
Raw Label Data
All Sections (JSON)
Additional Information
Back to search View SPL set listing Open on DailyMed ↗
Source: dailymed · Ingested: 2026-02-15T12:00:04.242489 · Updated: 2026-03-14T23:00:23.363901